Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1

被引:40
作者
Koziczak, M [1 ]
Krek, W [1 ]
Nagamine, Y [1 ]
机构
[1] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
关键词
D O I
10.1128/MCB.20.6.2014-2022.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of genes of the plasminogen activator (PA) system declines at the G(o)/G(1)-S-phase boundary of the cell cycle. We found that overexpression of E2F1-3, which acts mainly in late G(1), inhibits promoter activity and endogenous expression of the urokinase-type PA (uPA) and PA inhibitor 1 (PAI-1) genes. This effect is dose dependent and conserved in evolution. Mutation analysis indicated that both the DNA-binding and transactivation domains of E2F1 are necessary for this regulation. Interestingly, an E2F1 mutant lacking the pRB-binding region strongly repressed the uPA and PAI-I promoters. An E2F-mediated negative effect was also observed in pRB and p107/p130 knockout cell lines. This is the first report that E2F can act as a repressor independently of pocket proteins, Mutation of AP-I elements in the uPA promoter abrogated E2F-mediated transcriptional inhibition, suggesting the involvement of AP-1 in this regulation. Results shown here identify E2F as an important component of transcriptional control of the PA system and thus provide new insights into mechanisms of cellular proliferation.
引用
收藏
页码:2014 / 2022
页数:9
相关论文
共 72 条
[41]   THE RETINOBLASTOMA PROTEIN BINDS TO A FAMILY OF E2F TRANSCRIPTION FACTORS [J].
LEES, JA ;
SAITO, M ;
VIDAL, M ;
VALENTINE, M ;
LOOK, T ;
HARLOW, E ;
DYSON, N ;
HELIN, K .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) :7813-7825
[42]   E2F3 activity is regulated during the cell cycle and is required for the induction of S phase [J].
Leone, G ;
DeGregori, J ;
Yan, Z ;
Jakoi, L ;
Ishida, S ;
Williams, RS ;
Nevins, JR .
GENES & DEVELOPMENT, 1998, 12 (14) :2120-2130
[43]   The subcellular localization of E2F-4 is cell-cycle dependent [J].
Lindeman, GJ ;
Gaubatz, S ;
Livingston, DM ;
Ginsberg, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5095-5100
[44]   STIMULATION OF E2F1/DP1 TRANSCRIPTIONAL ACTIVITY BY MDM2 ONCOPROTEIN [J].
MARTIN, K ;
TROUCHE, D ;
HAGEMEIER, C ;
SORENSEN, TS ;
LATHANGUE, NB ;
KOUZARIDES, T .
NATURE, 1995, 375 (6533) :691-694
[45]   The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins [J].
McMahon, SB ;
Van Buskirk, HA ;
Dugan, KA ;
Copeland, TD ;
Cole, MD .
CELL, 1998, 94 (03) :363-374
[46]  
MEDCALF RL, 1990, J BIOL CHEM, V265, P14618
[47]   Polyomavirus middle-T antigen lacking a membrane anchor sequence accumulates in the nucleus [J].
Messerschmitt, A ;
Disela, C ;
Dilworth, S ;
Marti, AG ;
BallmerHofer, K .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :17-26
[48]  
Moberg K, 1996, MOL CELL BIOL, V16, P1436
[49]   A GENE-THERAPY STRATEGY USING A TRANSCRIPTION FACTOR DECOY OF THE E2F BINDING-SITE INHIBITS SMOOTH-MUSCLE PROLIFERATION IN-VIVO [J].
MORISHITA, R ;
GIBBONS, GH ;
HORIUCHI, M ;
ELLISON, KE ;
NAKAJIMA, M ;
ZHANG, L ;
KANEDA, Y ;
OGIHARA, T ;
DZAU, VJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) :5855-5859
[50]  
Mu XC, 1998, J CELL PHYSIOL, V174, P90, DOI 10.1002/(SICI)1097-4652(199801)174:1<90::AID-JCP10>3.0.CO